Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution... see more

Bullboard (TSXV:WAVE)

View:
Post by Goldblackon Aug 11, 2020 10:15am

Wave --new "Sedar" filing

As of 07/31/2020 an institutional investor(MMCAP International inc) now owns 4.773 mil sharers or 8.84% of issued capital.GLTA
Comment by bullmarketson Aug 10, 2020 10:48am

RE:Too expensive, sold and waiting

I thought anything under .25 was good , so .17 is great , can only buy so much.  --covid and Fda on billion dollar drugs, with a tight float. Will run again. 
Post by moneywinner1on Aug 10, 2020 9:59am

Too expensive, sold and waiting

It is going down as insiders selling and faccukp market maker .  they have what it takes for a run but they are not run for shareholders 
Comment by tankingfrankon Aug 10, 2020 9:58am

RE:RE:RE:In at .175 average for a trade

there is 12 million free trading shares, thessien owns 40 million shares ( basically cant sell it ) . some of that 12 million will be locked up for the long term. 
Comment by yixteron Aug 07, 2020 11:49pm

RE:RE:RE:RE:In at .175 average for a trade

This one is already making some pretty decent revs lol.
Comment by bigkaganon Aug 07, 2020 11:15pm

RE:RE:RE:In at .175 average for a trade

this thing could be another IPCI on which I burned myself real bad when I didn't sell before FDA rejected its safe Oxy pill. These Canadian generic drug companies are no good no matter what drugs ...more  
Comment by Grose1987on Aug 07, 2020 2:14pm

RE:In at .175 average for a trade

In for trade End Of Month 
Comment by tankingfrankon Aug 07, 2020 1:06pm

RE:RE:Pink, Claude, Jerico...

looks like the trend might reverse. need some volume to confirm.   then some covid news or FDA and higher we go.. 
Comment by bullmarketson Aug 07, 2020 10:36am

RE:Cheap Sellers have dried up ?

Maybe, lot of traders are dumb, and chase on news 
Comment by Grandpawon Aug 07, 2020 10:30am

RE:RE:Pink, Claude, Jerico...

Sorry Rosehip, didn't know you were here too! 
Post by Goldblackon Aug 07, 2020 10:30am

Cheap Sellers have dried up ?

Time to move back up!!
Comment by tankingfrankon Aug 07, 2020 10:04am

RE:RE:RE:RE:RE:No body wants to buy this garbage

they have a good partner ( reliance life) part of reliance group last raise was 50 cents  3 years or so ago.   low float low cash burn.  working on billion dollar drugs with ...more  
Comment by tankingfrankon Aug 07, 2020 9:58am

RE:RE:RE:RE:No body wants to buy this garbage

small cap mkt is news driven, and a good portion of people ahve little understanding of what they are actually buying. so it depends on how many weak hands are left and when news drops (IMO). 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities